227 related articles for article (PubMed ID: 17560598)
1. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms.
Turner NA; Aley PK; Hall KT; Warburton P; Galloway S; Midgley L; O'Regan DJ; Wood IC; Ball SG; Porter KE
J Mol Cell Cardiol; 2007 Aug; 43(2):168-76. PubMed ID: 17560598
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin.
Porter KE; Turner NA; O'Regan DJ; Ball SG
Cardiovasc Res; 2004 Dec; 64(3):507-15. PubMed ID: 15537504
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
Turner NA; O'Regan DJ; Ball SG; Porter KE
FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
[TBL] [Abstract][Full Text] [Related]
6. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.
Cho HJ; Jeong YJ; Park KK; Park YY; Chung IK; Lee KG; Yeo JH; Han SM; Bae YS; Chang YC
J Ethnopharmacol; 2010 Feb; 127(3):662-8. PubMed ID: 19969058
[TBL] [Abstract][Full Text] [Related]
7. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
8. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
11. 3,4,5-trihydroxybenzaldehyde from Geum japonicum has dual inhibitory effect on matrix metalloproteinase 9; inhibition of gelatinoytic activity as well as MMP-9 expression in TNF-alpha induced HASMC.
Suh SJ; Cho KJ; Moon TC; Chang HW; Park YG; Kim CH
J Cell Biochem; 2008 Oct; 105(2):524-33. PubMed ID: 18773430
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
13. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
Hsiang CY; Wu SL; Chen JC; Lo HY; Li CC; Chiang SY; Wu HC; Ho TY
Toxicol Lett; 2007 Jun; 171(1-2):78-86. PubMed ID: 17543481
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
15. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts.
Park IH; Park SJ; Cho JS; Moon YM; Moon JH; Kim TH; Lee SH; Lee HM
Am J Rhinol Allergy; 2012; 26(1):7-11. PubMed ID: 22391067
[TBL] [Abstract][Full Text] [Related]
17. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation.
Harvey KA; Paranavitana CN; Zaloga GP; Siddiqui RA
J Cell Physiol; 2007 May; 211(2):353-63. PubMed ID: 17167780
[TBL] [Abstract][Full Text] [Related]
18. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
19. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
20. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
